Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2015
Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer
Marc A Schneider, Martin Granzow, Arne Warth, et al.
International Journal of Oncology
|
February 25, 2022
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma
Marc A Schneider, Sarah Richtmann, Anna R Gründing, et al.
Journal of the American Chemical Society
|
May 23, 2012
The effect of solvent additives on morphology and excited-state dynamics in PCPDTBT:PCBM photovoltaic blends
Fabian Etzold, Ian A Howard, Nina Forler, et al.
BMC Cancer
|
May 10, 2011
Loss of aquaporin-4 expression and putative function in non-small cell lung cancer
Arne Warth, Thomas Muley, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 20, 2008
Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes
Ruprecht Kuner, Thomas Muley, Michael Meister, et al.
Anticancer Research
|
December 27, 2011
The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer
Esther Herpel, Katrin Jensen, Thomas Muley, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 16, 2023
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission
Thomas Muley, Felix J Herth, Claus Peter Heussel, et al.
Cancer Research
|
July 12, 2022
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers
Timo B Trefzer, Marc A Schneider, Katharina Jechow, et al.
Cancers
|
May 15, 2019
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
Sarah Richtmann, Dennis Wilkens, Arne Warth, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung
Thomas Muley, Ying He, Vinzent Rolny, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2015
Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer
Marc A Schneider, Martin Granzow, Arne Warth, et al.
International Journal of Oncology
|
February 25, 2022
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma
Marc A Schneider, Sarah Richtmann, Anna R Gründing, et al.
Journal of the American Chemical Society
|
May 23, 2012
The effect of solvent additives on morphology and excited-state dynamics in PCPDTBT:PCBM photovoltaic blends
Fabian Etzold, Ian A Howard, Nina Forler, et al.
BMC Cancer
|
May 10, 2011
Loss of aquaporin-4 expression and putative function in non-small cell lung cancer
Arne Warth, Thomas Muley, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 20, 2008
Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes
Ruprecht Kuner, Thomas Muley, Michael Meister, et al.
Anticancer Research
|
December 27, 2011
The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer
Esther Herpel, Katrin Jensen, Thomas Muley, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 16, 2023
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission
Thomas Muley, Felix J Herth, Claus Peter Heussel, et al.
Cancer Research
|
July 12, 2022
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers
Timo B Trefzer, Marc A Schneider, Katharina Jechow, et al.
Cancers
|
May 15, 2019
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
Sarah Richtmann, Dennis Wilkens, Arne Warth, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung
Thomas Muley, Ying He, Vinzent Rolny, et al.
Page
of 12